Word

GLYPH

Status

Pending

Status Code

730

Status Date

Saturday, January 27, 2024

Serial Number

90811136

Mark Type

4000

Filing Date

Monday, July 5, 2021

Published for Opposition

Tuesday, June 6, 2023

Trademark Owner History

PureTech Health LLC - Owner At Publication

Classifications

5 Technologies in the nature of pharmaceutical preparations of drugs that facilitate the delivery of pharmaceutical compounds for oral administration of therapeutics utilizing the lymphatic system to treat human and animal disease and illness, namely infectious diseases, inflammatory disorders, respiratory diseases, cardiovascular diseases, autoimmune disorders, gastrointestinal disorders, cancer, hematological diseases, neurological diseases, neuropsychiatric disorders, hepatic diseases, renal diseases, lymphatic disorders, metabolic disorders, genetic disorders, dermatological disorders, ocular diseases, and orphan diseases

35 commercialization, namely, commercial consultancy in the pharmaceutical and biotechnology fields

42 research and development in the pharmaceutical and biotechnology fields

Trademark Events

Jan 30, 2024

Notice Of Approval Of Extension Request E-Mailed

Jan 27, 2024

Sou Extension 1 Granted

Jan 27, 2024

Sou Extension 1 Filed

Jan 27, 2024

Sou Teas Extension Received

Aug 1, 2023

Noa E-Mailed - Sou Required From Applicant

Jun 6, 2023

Official Gazette Publication Confirmation E-Mailed

Jun 6, 2023

Published For Opposition

May 17, 2023

Notification Of Notice Of Publication E-Mailed

May 3, 2023

Approved For Pub - Principal Register

May 2, 2023

Examiner's Amendment Entered

May 2, 2023

Notification Of Examiners Amendment E-Mailed

May 2, 2023

Examiners Amendment E-Mailed

May 2, 2023

Examiners Amendment -Written

Nov 9, 2022

Notification Of Final Refusal Emailed

Nov 9, 2022

Final Refusal E-Mailed

Nov 9, 2022

Final Refusal Written

Sep 27, 2022

Teas/Email Correspondence Entered

Sep 27, 2022

Correspondence Received In Law Office

Sep 27, 2022

Teas Response To Office Action Received

Aug 30, 2022

Assigned To Examiner

Mar 29, 2022

Notification Of Non-Final Action E-Mailed

Mar 29, 2022

Non-Final Action E-Mailed

Mar 29, 2022

Non-Final Action Written

Mar 24, 2022

Assigned To Examiner

Sep 14, 2021

New Application Office Supplied Data Entered

Jul 8, 2021

New Application Entered